Decreased risk of hepatocellular carcinoma in patients with chronic hepatitis C whose serum alanine aminotransferase levels became less than twice the upper limit of normal following interferon therapy.

Source:http://linkedlifedata.com/resource/pubmed/id/15698403

Download in:

View as

General Info

PMID
15698403